Truvian

Truvian is a healthcare company at the intersection of diagnostics and consumer tech. We are disrupting the blood testing industry by developing an automated, benchtop diagnostic system to provide lab-accurate results in 20 minutes for a comprehensive suite of health tests. Our proprietary approach, for which we are seeking FDA clearance, is intended to fulfill the promise of delivering accessible and affordable blood testing from one small blood sample, in minutes, in a retail setting or private clinic. Truvian has also expanded our focus to address the surge in demand for antibody tests by introducing Easy Check COVID-19 IgM/IgG antibody test. This test will create higher standards of performance, speed, and scalability for the rapid detection of IgM/IgG antibodies to SARS-CoV-2.